• Aucun résultat trouvé

on the Use of Medicinal Products for the Treatment of Patients Exposed to

N/A
N/A
Protected

Academic year: 2021

Partager "on the Use of Medicinal Products for the Treatment of Patients Exposed to "

Copied!
29
0
0

Texte intégral

Figure

Table 1: Antidotes for organic arsenicals
Table 2: Classification of severity of acute symptoms after nerve agents exposure
Table 3: Medicinal treatment recommendations for nerve agents and other highly toxic  organophosphates
Table 4: Summary of Cyanide Intoxication Antidote Treatments
+3

Références

Documents relatifs

SUHVHQWVUHFHQWZRUNVFDUULHGRXWRQXVLQJ&DORQHDQG&FRXSOHGWRRWKHUWUHDWPHQWPHWKRGV DLPLQJDWWUHDWLQJZDVWHZDWHU

At lower resolutions of histological imagery, textural analysis is commonly used to capture tissue architecture, i.e., the overall pattern of glands, stroma and organ organization.

Katarzyna Bandurska, Department of Microbiology and Biotechnology, Institute of Chemistry, Environmental Protection and Biotechnology, Jan Dlugosz University in

This talk will provide an overview of this new challenging area of research, by analyzing empathy in the social relations established between humans and social agents (virtual

The agents that cause infant diar- rhoea have been largely identified, and vaccine candidates against most of the important pathogens (rotavirus, enterotoxigenic E.

LtdChinaChina othion WP (2 g/m2 active ingredient)Ki-Hara Chemicals LtdUnited KingdomNo information provided othion WP (2 g/m2 active ingredient)Sumitomo Chemical Co.

Considering the positive scientific opinion of artesunate-pyronaridine under the European Medicines Agency (EMA)’s Article 58, its inclusion in the WHO list of prequalified

Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder.. Urology